<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zheng Y</submitter><funding>NINDS NIH HHS</funding><funding>United States Department of Defense</funding><funding>Craig H Neilsen Foundation</funding><funding>NIH HHS</funding><pagination>8940</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12469384</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(18)</volume><pubmed_abstract>Human induced pluripotent stem cells (hiPSCs) hold great potential for patient-specific therapies. Transplantation of hiPSC-derived neural progenitor cells (NPCs) is a promising reparative strategy for spinal cord injury (SCI), but clinical translation requires efficient differentiation into desired neural lineages and purification before transplantation. Here, differentiated hiPSCs-reprogrammed from human skin fibroblasts using Sendai virus-mediated expression of OCT4, SOX2, KLF4, and C-MYC-into neural rosettes expressing SOX1 and PAX6, followed by neuronal precursors (β-tubulin III&lt;sup>+&lt;/sup>/NESTIN&lt;sup>+&lt;/sup>) and glial precursors (GFAP+/NESTIN+). Both neuronal and glial precursors expressed the A2B5 surface antigen. A2B5+ NPCs, purified by fluorescence-activated cell sorting (FACS), </pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Functional Recovery by Transplantation of Human iPSC-Derived A2B5 Positive Neural Progenitor Cell After Spinal Cord Injury in Mice.</pubmed_title><pmcid>PMC12469384</pmcid><funding_grant_id>R01 NS061975</funding_grant_id><funding_grant_id>385446</funding_grant_id><funding_grant_id>338617</funding_grant_id><funding_grant_id>1R01NS110707-01</funding_grant_id><funding_grant_id>R01 NS110707</funding_grant_id><funding_grant_id>1R01NS099635-01</funding_grant_id><funding_grant_id>HT9425-25-1-0376</funding_grant_id><pubmed_authors>Kim DH</pubmed_authors><pubmed_authors>Xia X</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Bu P</pubmed_authors><pubmed_authors>Zhou H</pubmed_authors><pubmed_authors>Xue H</pubmed_authors><pubmed_authors>Cao Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Functional Recovery by Transplantation of Human iPSC-Derived A2B5 Positive Neural Progenitor Cell After Spinal Cord Injury in Mice.</name><description>Human induced pluripotent stem cells (hiPSCs) hold great potential for patient-specific therapies. Transplantation of hiPSC-derived neural progenitor cells (NPCs) is a promising reparative strategy for spinal cord injury (SCI), but clinical translation requires efficient differentiation into desired neural lineages and purification before transplantation. Here, differentiated hiPSCs-reprogrammed from human skin fibroblasts using Sendai virus-mediated expression of OCT4, SOX2, KLF4, and C-MYC-into neural rosettes expressing SOX1 and PAX6, followed by neuronal precursors (β-tubulin III&lt;sup>+&lt;/sup>/NESTIN&lt;sup>+&lt;/sup>) and glial precursors (GFAP+/NESTIN+). Both neuronal and glial precursors expressed the A2B5 surface antigen. A2B5+ NPCs, purified by fluorescence-activated cell sorting (FACS), </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-02T03:17:28.123Z</modification><creation>2026-05-02T03:11:25.776Z</creation></dates><accession>S-EPMC12469384</accession><cross_references><pubmed>41009511</pubmed><doi>10.3390/ijms26188940</doi></cross_references></HashMap>